Avadel Pharmaceuticals (FRA:AWK) Other Long-Term Liabilities : €37.04 Mil (As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Avadel Pharmaceuticals Other Long-Term Liabilities?

Avadel Pharmaceuticals's other long-term liabilities for the quarter that ended in Mar. 2024 was €37.04 Mil.

Avadel Pharmaceuticals's quarterly other long-term liabilities increased from Sep. 2023 (€29.48 Mil) to Dec. 2023 (€35.23 Mil) and increased from Dec. 2023 (€35.23 Mil) to Mar. 2024 (€37.04 Mil).

Avadel Pharmaceuticals's annual other long-term liabilities increased from Dec. 2021 (€3.47 Mil) to Dec. 2022 (€5.42 Mil) and increased from Dec. 2022 (€5.42 Mil) to Dec. 2023 (€35.23 Mil).

Avadel Pharmaceuticals Other Long-Term Liabilities Historical Data

The historical data trend for Avadel Pharmaceuticals's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avadel Pharmaceuticals Other Long-Term Liabilities Chart

Avadel Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Avadel Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Avadel Pharmaceuticals Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Avadel Pharmaceuticals Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Avadel Pharmaceuticals's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Avadel Pharmaceuticals (FRA:AWK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Avadel Pharmaceuticals PLC (FRA:AWK) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

AVDL:USA AWK1:Germany

Address

10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380

Website

https://www.avadel.com

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company markets products in both the primary care and sterile injectables markets. Its products portfolio includes Bloxiverz, Vazculep (phenylephrine hydrochloride injection), Akovaz (ephedrine sulfate injection), Karbinal ER (carbinoxamine maleate extended-release oral suspension), AcipHex Sprinkle (rabeprazole sodium), Cefaclor for Oral Suspension, 125 mg/5 mL, 250 mg/5 mL and 375 mg/5 mL, and Flexichamber. Majority of the revenue is derived from the United States.